We are live on ! Find out more
CM

CM Management Portfolio holdings

AUM $120M
1-Year Est. Return 37.12%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.12%
3 Year Est. Return
+141.34%
5 Year Est. Return
+139.46%
10 Year Est. Return
–
AUM
$134M
AUM Growth
-$4.28M
Cap. Flow
-$3.27M
Cap. Flow %
-2.44%
Top 10 Hldgs %
36.56%
Holding
98
New
12
Increased
28
Reduced
7
Closed
7

Top Buys

1
KMI icon
Kinder Morgan
KMI
+$1.7M
2
OGN icon
Organon & Co
OGN
+$640K
3
GTX icon
Garrett Motion
GTX
+$575K
4
TBPH icon
Theravance Biopharma
TBPH
+$559K
5
VZ icon
Verizon
VZ
+$553K

Top Sells

1
CLDR
Cloudera, Inc.
CLDR
+$6.74M
2
PFE icon
Pfizer
PFE
+$1.96M
3
SD icon
SandRidge Energy
SD
+$1.76M
4
CYTK icon
Cytokinetics
CYTK
+$1.47M
5
BMY icon
Bristol-Myers Squibb
BMY
+$1.34M

Sector Composition

1 Healthcare 38.49%
2 Financials 15.34%
3 Energy 13.23%
4 Materials 7.47%
5 Technology 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GANX icon
76
Gain Therapeutics
GANX
$71.2M
$479K 0.36%
64,327
+54,327
+543% +$454K
ELDN icon
77
Eledon Pharmaceuticals
ELDN
$310M
$464K 0.35%
75,000
– –
AE
78
DELISTED
Adams Resources & Energy Inc
AE
$456K 0.34%
+15,000
New +$428K
AMSC icon
79
American Superconductor
AMSC
$1.63B
$437K 0.33%
+30,000
New +$416K
HPE icon
80
Hewlett Packard
HPE
$61.4B
$428K 0.32%
30,000
– –
FEMY icon
81
Femasys
FEMY
$8.91M
$413K 0.31%
3,000
– –
KHC icon
82
Kraft Heinz
KHC
$30.6B
$368K 0.27%
+10,000
New +$377K
SVC
83
Service Properties Trust
SVC
$1.11B
$280K 0.21%
+5,000
New +$284K
NBSE
84
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$271K 0.2%
+3,750
New +$287K
T icon
85
AT&T
T
$151B
$270K 0.2%
+13,240
New +$278K
NEUE
86
DELISTED
NeueHealth
NEUE
$204K 0.15%
+313
New +$275K
PTPI
87
DELISTED
Petros Pharmaceuticals
PTPI
$200K 0.15%
400
– –
VYNE icon
88
VYNE Therapeutics
VYNE
$25.2M
$200K 0.15%
7,986
– –
CRTD
89
DELISTED
Creatd Inc. Common Stock
CRTD
$163K 0.12%
60,000
-130,000
-68% -$426K
AUID icon
90
authID Inc
AUID
$15.2M
$112K 0.08%
+1,250
New +$113K
CRTDW
91
DELISTED
Creatd Inc. Warrant
CRTDW
$72K 0.05%
103,400
+81,017
+362% +$106K
ATER icon
92
Aterian
ATER
$14.3M
– –
-4,167
Closed -$732K
BMY icon
93
Bristol-Myers Squibb
BMY
$124B
– –
-20,000
Closed -$1.34M
PFE icon
94
Pfizer
PFE
$143B
– –
-50,000
Closed -$1.96M
SD icon
95
SandRidge Energy
SD
$505M
– –
-280,000
Closed -$1.76M
TAOX
96
Tao Synergies Inc
TAOX
$26.5M
– –
-400
Closed -$99K
TEVA icon
97
Teva Pharmaceuticals
TEVA
$37.3B
– –
-25,000
Closed -$248K
CLDR
98
DELISTED
Cloudera, Inc.
CLDR
– –
-425,000
Closed -$6.74M
1 2 3
4

Similar funds

AA
Ahara Advisors Jersey City, New Jersey $120M AUM
CC
Commons Capital Needham, Massachusetts $120M AUM 31.45% 1-Year Est. Return
DG
Dala Group Hoffman Estates, Illinois $120M AUM
ACM
AIHC Capital Management Central $120M AUM
WAG
Windsor Advisory Group Columbus, Ohio $120M AUM 4.29% 1-Year Est. Return
YMRC
Yorktown Management & Research Company Forest, Virginia $120M AUM 52.72% 1-Year Est. Return
IW
Integrated Wealthcare Durham, North Carolina $120M AUM
BCWM
Ball & Co Wealth Management Franklin, Tennessee $120M AUM 21.28% 1-Year Est. Return

CM Management's Q3 2021 Portfolio in Review

As of Q3 2021, CM Management held 98 positions worth $134M, down 3.1% from $138M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

CM Management's Q3 2021 filing shows 12 new, 28 increased, 7 reduced and 7 closed positions. Its largest new stake was Kinder Morgan: 100,000 shares worth $1.67M. The largest sale was Cloudera, Inc., an estimated $6.74M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Financials and Energy.

  • CM Management's largest Q3 2021 buy was Kinder Morgan: 100,000 shares worth $1.67M.
  • CM Management added most to Organon & Co in Q3 2021, an estimated $640K increase.
  • CM Management's biggest Q3 2021 reduction was Cytokinetics, cutting an estimated $1.47M.
  • CM Management fully exited Cloudera, Inc. in Q3 2021, selling an estimated $6.74M.
  • CM Management's ten largest holdings make up 37% of its $134M portfolio in Q3 2021.
  • CM Management opened 12 new positions and closed 7 in Q3 2021.
  • CM Management's portfolio value fell 3.1% quarter-over-quarter to $134M.

Based on CM Management's 13F filing for Q3 2021, filed 8 Nov 2021.